Announcement on Adjusting the Development Strategy of BAT3306 (Pembrolizumab)

About this update from Bio-thera Solutions, Ltd. Class A

Announcement on Adjusting the Development Strategy of BAT3306 (Pembrolizumab) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Bio-thera Solutions, Ltd. Class A